5-fluorocytosine


Also found in: Acronyms.

5-fluorocytosine

References in periodicals archive ?
Total Nesting Procedure Format (a) Characters (b) Tags (c) Levels (d) 5-Fluorocytosine Plain text 23 257 by HPLC CLP-ML 36 504 614 10 CDA XML 43 386 741 12 MS Word (e) 136 704 CKMB automated Plain text 13 484 immunoassay CLP-ML 18 465 271 7 CDA XML 19 801 258 9 MS Word (e) 52 224 Prothrombin and Plain text 15 029 partial CLP-ML 17 982 275 7 thromboplastin CDA XML 20 679 306 11 times (manual) Streptococcal Plain text 3383 screen CLP-ML 4935 86 6 CDA XML 5672 87 7 (a) Plain text and XML files were ASCII text with Unix line endings (lines terminated with a single linefeed character).
However, when both ifosfamide and 5-fluorocytosine were administered, the combination proved to be superior in cancer-killing ability than ifosfamide alone.
In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
Despite treatment with pentamidine, 5-fluorocytosine, and itraconazole, the infection was rapidly fatal.
5 mL) containing blood agar made from defibrinated rabbit blood overlaid with a 1:1 mixture of RPMI 1640 medium and Schneider Drosophila cell culture medium supplemented with 10% fetal calf serum (Sigma, Saint Louis, MO, USA, and Gibco-BRL, Gaithersburg, MD, USA), 10,000 IU penicillin (Biotika, L'upca, Slovakia), 100 [micro]g/mL amikacin (Bristol-Myers Squibb, Princeton, NJ, USA), and 1,500 [micro]g/mL 5-fluorocytosine (Sigma).
The first such gene is cytosine deaminase (CD) which encodes an enzyme that converts an inactive, prodrug 5-fluorocytosine to the toxic chemotherapeutic 5-fluorourocil at the site of the tumor.
Each patient will also be given 5-fluorocytosine (5-FC) to take orally.
The enzyme can convert the systemically administered drug, 5-fluorocytosine (5-FC), an agent with minimal toxicity, into the anticancer agent, 5-fluorouracil (5-FU).
activated) in cancer cells infected with the virus and that it was able to convert 5-fluorocytosine, a non-toxic prodrug (5-FC) to 5-fluorouracil (5-FU), a toxic agent used in standard chemotherapy.
Cytosine deaminase is an enzyme that converts a marketed prodrug 5-fluorocytosine (5FC) to its active form 5-fluorouracil (5FU) and carboxylesterase converts anticancer agent, topoisomerase I inhibitors, into its active form, SN-38.